Company intelligence / Profile preview
Cyrus Therapeutics
Seattle, Washington, United States
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Cyrus has developed a pipeline of novel biologic candidates using its proprietary AI-driven protein engineering platform. Lead assets include an IL‑22 fusion protein showing superior efficacy in preclinical models for autoimmune/metabolic disease and patented ACE2 receptor variants validated as SARS-CoV‑2 decoys with resistance to new COVID strains. The company has numerous industry partnerships and continues advancing its early-stage pipeline toward clinical development.
- Therapeutic areas
- OtherMetabolic DisordersImmunologyInfectious Diseases
- Modalities
- Protein therapeuticsbiologics (including fusion proteins and engineered variants)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Janssen PharmaceuticalsSelecta BiosciencesOver ninety industry partners including global pharma companiesAcademic collaborations with University of Washington/Baker Lab
Beyond the preview
Go deeper on Cyrus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyrus Therapeutics.